Health Care

Valeant Gets Lender OK to Amend Debt Terms

Valeant Pharmaceuticals International on Thursday said it secured a commitment from loan holders to amend terms of its debt, buying time as the drugmaker attempts to resuscitate itself.

New Tax Rules Are Met With Protest

A day after the Obama administration limited the ability of U.S. companies to do international deals to lighten their tax burdens, Pfizer and Allergan terminated their planned $150 billion merger and other companies around the globe raced to assess the impact of the new rules.

UnitedHealth to Leave California's ACA Exchange

UnitedHealth told brokers that it has filed paperwork to offer plans in just six states' health-law marketplaces next year, providing the most complete picture so far of its previously announced widespread withdrawal.

UnitedHealth to Leave California's ACA Exchange

UnitedHealth told brokers that it has filed paperwork to offer plans in just six states' health-law marketplaces next year, providing the most complete picture so far of its previously announced widespread withdrawal.

Walgreens Quarterly Profit Beats Estimates

Walgreens Boots Alliance reported a 2.4 percent rise in quarterly sales, helped by demand for Medicare Part D drugs and non-pharmacy products in the United States.

Analysis Suggests Anthem Deal Could Raise Health Costs

As questions mount over whether health insurer Anthem Inc's proposed $48 billion purchase of Cigna Corp will win U.S. antitrust approval, an exclusive analysis produced for Reuters suggests the merger could lead to higher costs for large companies offering workplace medical benefits.